ACC.17

Study patients were randomized to Pradaxa 150mg twice daily or warfarin (target INR 2-3) and remained on this treatment for the trial duration.

Results showed a similar change in baseline raw score of spatial working memory strategy index of executive function in the evolocumab and placebo groups (mean change from baseline -0.2 vs. -0.3, respectively).

The study researchers evaluated 45,029 new PCSK9 inhibitor prescription claims in one retrospective study.

During the past 2 decades, the use of antihypertensive drug use has “increased remarkably,” noted Jens Sundboll, of Aarhus University Hospital, Aarhus, Denmark

When compared to bivalirudin, higher bleeding complications and all-cause mortality were seen with unfractionated heparin among patients undergoing PCI.

Although MI is known to be common among patients with CKD, not much is known about the incidence of post-MI bleeding and premature P2Y12 inhibitor therapy cessation among these patients.

Study authors reported that sacubitril/valsartan was effective in both ischemic and non-ischemic cardiomyopathy, including the major subgroups of non-ischemic etiology.

Patients undergoing PCI were randomized at the time of angiography to receive either cangrelor or clopidogrel.

Extended use of betrixaban beyond the usual period of parenteral prophylaxis with enoxaparin reduced venous thromboembolism (VTE) incidence among medically ill patients.